GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clever Leaves Holdings Inc (NAS:CLVR) » Definitions » Beneish M-Score

Clever Leaves Holdings (Clever Leaves Holdings) Beneish M-Score : -3.26 (As of May. 03, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Clever Leaves Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.26 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Clever Leaves Holdings's Beneish M-Score or its related term are showing as below:

CLVR' s Beneish M-Score Range Over the Past 10 Years
Min: -4.21   Med: -3.26   Max: -1.84
Current: -3.26

During the past 5 years, the highest Beneish M-Score of Clever Leaves Holdings was -1.84. The lowest was -4.21. And the median was -3.26.


Clever Leaves Holdings Beneish M-Score Historical Data

The historical data trend for Clever Leaves Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clever Leaves Holdings Beneish M-Score Chart

Clever Leaves Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -1.84 -4.21 -3.26

Clever Leaves Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.21 -3.96 -4.72 -5.24 -3.26

Competitive Comparison of Clever Leaves Holdings's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Clever Leaves Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clever Leaves Holdings's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Clever Leaves Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Clever Leaves Holdings's Beneish M-Score falls into.



Clever Leaves Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Clever Leaves Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4599+0.528 * 1.1684+0.404 * 0.6542+0.892 * 1.0614+0.115 * 1.0892
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7338+4.679 * -0.073681-0.327 * 1.0102
=-3.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $2.08 Mil.
Revenue was 4.638 + 3.82 + 4.981 + 3.978 = $17.42 Mil.
Gross Profit was -0.346 + 1.942 + 2.726 + 2.234 = $6.56 Mil.
Total Current Assets was $13.94 Mil.
Total Assets was $31.24 Mil.
Property, Plant and Equipment(Net PPE) was $13.15 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.85 Mil.
Selling, General, & Admin. Expense(SGA) was $20.05 Mil.
Total Current Liabilities was $5.81 Mil.
Long-Term Debt & Capital Lease Obligation was $1.20 Mil.
Net Income was -5.085 + -5.138 + -3.595 + -4.081 = $-17.90 Mil.
Non Operating Income was -0.111 + -3.889 + -0.051 + -0.038 = $-4.09 Mil.
Cash Flow from Operations was -1.543 + -2.201 + -1.687 + -6.077 = $-11.51 Mil.
Total Receivables was $4.26 Mil.
Revenue was 4.402 + 2.867 + 4.1 + 5.041 = $16.41 Mil.
Gross Profit was 0.844 + 1.299 + 2.481 + 2.593 = $7.22 Mil.
Total Current Assets was $26.25 Mil.
Total Assets was $52.10 Mil.
Property, Plant and Equipment(Net PPE) was $15.27 Mil.
Depreciation, Depletion and Amortization(DDA) was $3.67 Mil.
Selling, General, & Admin. Expense(SGA) was $25.75 Mil.
Total Current Liabilities was $9.43 Mil.
Long-Term Debt & Capital Lease Obligation was $2.15 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.079 / 17.417) / (4.259 / 16.41)
=0.119366 / 0.259537
=0.4599

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(7.217 / 16.41) / (6.556 / 17.417)
=0.439793 / 0.376414
=1.1684

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (13.94 + 13.15) / 31.243) / (1 - (26.247 + 15.266) / 52.098)
=0.132926 / 0.203175
=0.6542

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=17.417 / 16.41
=1.0614

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3.672 / (3.672 + 15.266)) / (2.848 / (2.848 + 13.15))
=0.193896 / 0.178022
=1.0892

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(20.05 / 17.417) / (25.745 / 16.41)
=1.151174 / 1.56886
=0.7338

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.203 + 5.811) / 31.243) / ((2.152 + 9.426) / 52.098)
=0.224498 / 0.222235
=1.0102

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-17.899 - -4.089 - -11.508) / 31.243
=-0.073681

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Clever Leaves Holdings has a M-score of -3.26 suggests that the company is unlikely to be a manipulator.


Clever Leaves Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Clever Leaves Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Clever Leaves Holdings (Clever Leaves Holdings) Business Description

Traded in Other Exchanges
N/A
Address
19-B Parque Industrial Tibitoc, Tocancipá, Cundinamarca, Bodega, Colombia, BC, CAN
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments, 1. The Cannabinoid operating segment: is comprised of the Company's cultivation, extraction, and commercialization of cannabinoid products. 2. Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.
Executives
Andres Fajardo director, officer: President CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Julian Wilches officer: Chief Regulatory Officer CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Hague Henry R Iii officer: Chief Financial Officer 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Gary M Julien director ONE LANDMARK SQUARE, 22ND FLOOR, STAMFORD CT 06901
William Muecke director C/O CLEVER LEAVES HOLDINGS, 6501 CONGRESS AVE, SUITE 240, BOCA RATON FL 33487
David Kastin officer: General Counsel C/O VITAMIN SHOPPE, INC., SECAUCUS NJ 07094
Kyle Detwiler director, officer: Chief Executive Officer CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
George J Schultze 10 percent owner C/O SCHULTZE ASSET MANAGEMENT, LLC, 3000 WESTCHESTER AVENUE, PURCHASE NY 10577
Elisabeth H Demarse director CREDITCARDS.COM, 13809 RESEARCH BOULEVARD, SUITE 906, AUSTIN TX 78750
Etienne H. Deffarges director ACCRETIVE HEALTH, INC., 401 NORTH MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Schultze Special Purpose Acquisition Sponsor, Llc 10 percent owner 800 WESTCHESTER AVENUE, SUITE 632, RYE BROOK NY 10573
Amit Pandey officer: Interim CFO CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017